The national institutes of health attention-deficit/hyperactivity disorder consensus statement: Implications for practitioners and scientists

Peter S. Jensen

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Although the concept of pharmacotherapy for attention- deficit/hyperactivity disorder (ADHD) was first introduced more than 60 years ago, treatment of this disorder remains more controversial than ever. It is hoped, however, that the recent Consensus Development Conference (CDC) Statement on the diagnosis and treatment of ADHD will not only help answer some of the questions surrounding management of this disorder, but also lend needed scientific weight to debate in this area. While more research in ADHD is needed, the CDC participants pointed to a solid body of evidence showing that careful medication management can result in noticeable improvement in several measures, with little risk of adverse events.

Original languageEnglish (US)
Pages (from-to)29-33
Number of pages5
JournalCNS Spectrums
Volume5
Issue number6
DOIs
StatePublished - Jan 1 2000

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'The national institutes of health attention-deficit/hyperactivity disorder consensus statement: Implications for practitioners and scientists'. Together they form a unique fingerprint.

Cite this